急诊科癫痫持续状态苯二氮䓬类药物剂量优化
这项单中心回顾性分析纳入144例急诊癫痫持续状态成人患者,按初始苯二氮䓬剂量分为低剂量组(127例,88.2%)和指南剂量组(17例,11.8%)。低剂量组治疗升级率显著更高(69.3% vs 41.2%,p=0.029),住院时间和ICU停留时间更长(p=0.043和p=0.009),而苯二氮䓬相关不良事件无差异。初始剂量低于指南推荐、初始GCS较低和癫痫病史是治疗升级的显著预测因素。作者认为优先给予指南推荐的初始剂量可能有助于减少治疗升级和缩短疗程。
要点
- 急诊癫痫持续状态患者中仅11.8%(17/144)接受了指南推荐的苯二氮䓬初始剂量,88.2%(127/144)剂量不足。
- 低剂量组治疗升级率69.3% vs 指南剂量组41.2%(p=0.029),住院时间(p=0.043)和ICU停留时间(p=0.009)均显著更长。
- 两组的苯二氮䓬相关不良事件发生率无差异,低剂量并未提高安全性。
- 初始苯二氮䓬剂量低于指南推荐、初始GCS较低和既往癫痫病史是治疗升级的显著预测因素。
- 作者认为优先给予指南推荐的初始苯二氮䓬剂量可能有助于减少治疗升级和缩短疗程。
适用人群与场景
- 成人(平均年龄52岁,以男性为主)因癫痫持续状态到急诊科就诊并以苯二氮䓬类作为初始治疗的患者。
研究设计与关键结果
- 单中心回顾性分析,纳入144例成人癫痫持续状态患者,按初始苯二氮䓬剂量分为低剂量组127例(88.2%)和指南剂量组17例(11.8%)。
- 主要终点治疗升级率:低剂量组69.3% vs 指南剂量组41.2%(p=0.029),低剂量组显著更高。
- 低剂量组住院时间显著更长(p=0.043),ICU停留时间显著更长(p=0.009)。
- 对初始剂量后20分钟内累积苯二氮䓬用量的单独分析显示,两组治疗升级、住院时间、ICU停留时间和呼吸机依赖天数均无显著差异。
- 两项分析中苯二氮䓬相关不良事件发生率组间均无差异。
- 治疗升级的显著预测因素包括初始苯二氮䓬剂量低于指南推荐、初始GCS较低和既往癫痫病史。
证据类型、等级与局限
- 证据类型:单中心回顾性分析。
- 局限:原文未报告局限性。
对床旁实践的改变
- 作者认为,优先给予指南推荐的苯二氮䓬初始剂量可能有助于减少治疗升级和缩短疗程。
- 作者指出,未来需研究剂量不足的原因并评估可能影响结果的混杂因素。
提炼说明
- 本条依据论文摘要整理;摘要未涉及「诊断标准与关键阈值」「处置流程与药物剂量」「红旗征与不能漏的情况」「指南或共识出处」,故未列出这些栏目;全文请点「阅读原文」。
英文原文(摘要)· 点击展开
BACKGROUND/PURPOSE: Benzodiazepine (BZD) underdosing in status epilepticus (SE) occurs frequently due to perceived risk of respiratory or cardiovascular complications, despite data supporting the guideline-recommended doses of BZDs and evidence that untreated SE carries higher complication rates. The purpose of this study was to determine the incidence of treatment escalation in patients receiving lower than recommended BZD doses (underdosed group) compared with those who received at or above guideline-recommended doses (guideline-dosed group).
METHODS: This is a single-center retrospective analysis of adults presenting to the emergency department with SE who received BZDs as initial therapy. The primary outcome was incidence of treatment escalation, defined as endotracheal intubation (or attempted intubation) or need for a non-BZD second-line anti-seizure medication for ongoing seizure activity, between the underdosed group versus the guideline-dosed group. Secondary outcomes included hospital length of stay (LOS), intensive care unit (ICU) LOS, ventilator dependent days (VDD), and incidence of BZD-related adverse events. Multivariate logistic regression was used to identify predictors for treatment escalation.
RESULTS: One hundred forty-four patients met inclusion criteria (mean age 52 years; predominantly male). Based on initial BZD dose, 127 (88.2%) were categorized as underdosed and 17 (11.8%) as guideline-dosed. Patients in the underdosed group were significantly more likely to require treatment escalation (69.3% vs 41.2%; p = 0.029) and had significantly longer hospital LOS (p = 0.043) and ICU LOS (p = 0.009). A separate analysis of cumulative BZD administered within 20 min of the initial dose showed no significant differences between groups in treatment escalation, hospital LOS, ICU LOS, or VDD. Incidence of BDZ-related adverse events did not differ between groups in either analysis. Significant predictors for treatment escalation included an initial BZD dose below guideline recommendations, lower initial Glasgow Coma Scale (GCS), and past history of epilepsy.
CONCLUSION: Initial BZD underdosing in SE was associated with a higher rate of treatment escalation, and longer hospital and ICU LOS, without reducing adverse events. In this sample, underdosing appeared to be associated with adverse clinical consequences rather than improved safety. Though future studies are warranted into the reasoning for underdosing and evaluation of confounders which may impact results, our data demonstrate very few patients reach guideline recommended benzodiazepine dosing. Prioritizing guideline-recommended initial dosing may help minimize treatment escalation and reduce prolongation of care.
参考来源
- O'Keefe M, Feih J, Feldman R, et al. Optimization of benzodiazepine use for status epilepticus in the emergency department. Am J Emerg Med. 2026. PMID: 42013624. doi:10.1016/j.ajem.2026.04.005
供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。